Genpact Limited
G
$38.34
$0.060.16%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.29B | 1.25B | 1.21B | 1.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.29B | 1.25B | 1.21B | 1.25B |
| Cost of Revenue | 836.98M | 821.60M | 804.35M | 785.93M | 802.97M |
| Gross Profit | 482.29M | 469.66M | 450.07M | 428.99M | 445.77M |
| SG&A Expenses | 290.30M | 256.71M | 259.48M | 241.08M | 259.68M |
| Depreciation & Amortization | 7.37M | 8.29M | 4.32M | 4.32M | 6.50M |
| Other Operating Expenses | -14.00K | -110.00K | -44.00K | -112.00K | -55.00K |
| Total Operating Expenses | 1.13B | 1.09B | 1.07B | 1.03B | 1.07B |
| Operating Income | 184.64M | 204.78M | 186.32M | 183.70M | 179.65M |
| Income Before Tax | 188.83M | 189.35M | 176.74M | 175.22M | 182.55M |
| Income Tax Expenses | 45.74M | 43.52M | 44.02M | 44.37M | 40.63M |
| Earnings from Continuing Operations | 143.09M | 145.83M | 132.72M | 130.85M | 141.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 143.09M | 145.83M | 132.72M | 130.85M | 141.92M |
| EBIT | 184.64M | 204.78M | 186.32M | 183.70M | 179.65M |
| EBITDA | 210.21M | 230.46M | 207.26M | 204.41M | 203.53M |
| EPS Basic | 0.83 | 0.84 | 0.76 | 0.75 | 0.81 |
| Normalized Basic EPS | 0.69 | 0.71 | 0.64 | 0.62 | 0.65 |
| EPS Diluted | 0.82 | 0.83 | 0.75 | 0.73 | 0.79 |
| Normalized Diluted EPS | 0.68 | 0.70 | 0.63 | 0.61 | 0.64 |
| Average Basic Shares Outstanding | 171.85M | 173.58M | 174.61M | 175.53M | 175.88M |
| Average Diluted Shares Outstanding | 174.99M | 176.10M | 177.05M | 178.44M | 179.18M |
| Dividend Per Share | 0.17 | 0.17 | 0.17 | 0.17 | 0.15 |
| Payout Ratio | 20.30% | 20.09% | 22.32% | 22.76% | 18.81% |